UK Approval For Seretide MDI: Cipla
Kedar Upadhye, global CFO of Cipla, says the company has received approval for the Seretide MDI inhaler. This is a market with a $200 million size as Cipla will be the second generics player in the UK market, he adds.
![Gadgets 360 With Technical Guruji: Ask TG [May 24, 2025]](https://c.ndtvimg.com/2025-05/2g94tulc_ask-tg_160x120_24_May_25.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: Ask TG [May 24, 2025]")
![Gadgets 360 With Technical Guruji: News of the Week [May 24, 2025]](https://c.ndtvimg.com/2025-05/rk2jc2s_news-of-the-week_160x120_24_May_25.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: News of the Week [May 24, 2025]")
